Highly contingent phenotypes of Lon protease deficiency in Escherichia coli upon antibiotic challenge.
Evolutionary trajectories and mutational landscapes of drug-resistant bacteria are influenced by cell-intrinsic and extrinsic factors. In this study, I demonstrate that loss of the Lon protease alters susceptibility of Escherichia coli to trimethoprim, and these effects are strongly contingent on the drug concentration and genetic background. Lon, an AAA+ ATPase, is a bacterial master-regulator protease involved in cytokinesis, suppression of transposition events and clearance of misfolded proteins. I show that Lon-deficiency enhances intrinsic drug-tolerance at sub-MIC levels of trimethoprim. As a result, loss of Lon, though disadvantageous under drug-free conditions, has a selective advantage at low concentrations of trimethoprim. At high drug concentrations, however, Lon-deficiency is detrimental for E. coli I show that the former is explained by suppression of drug efflux by Lon, while the latter can be attributed to SulA-dependent hyper-filamentation. On the other hand, deletion of lon in a trimethoprim resistant mutant E. coli strain (harbouring the Trp30Gly dihydrofolate reductase (DHFR) allele) directly potentiates resistance by enhancing the in vivo stability of mutant DHFR. Using extensive mutational analysis at 3 hotspots of resistance, I show that many resistance-conferring mutations make DHFR prone to proteolysis. This trade-off between gaining resistance and losing in vivo stability limits the number of mutations in DHFR that can confer trimethoprim resistance. Loss of Lon expands the mutational capacity for acquisition of trimethoprim-resistance. This study identifies the multi-pronged action of Lon on trimethoprim-resistance in E. coli and provides mechanistic insight into how genetic backgrounds and drug concentrations may alter the potential for antimicrobial resistance evolution.ImportanceUnderstanding the evolutionary dynamics of antimicrobial resistance is vital to curb its emergence and spread. Being fundamentally similar to natural selection, fitness of resistant-mutants is a key parameter to consider in the evolutionary dynamics AMR. Various intrinsic and extrinsic factors modulate fitness of resistant-bacteria. This study demonstrates that Lon, a bacterial master regulator protease, influences drug-tolerance and resistance. Lon is a key regulator of several fundamental processes in bacteria, including cytokinesis. I demonstrate that Lon-deficiency produces highly contingent phenotypes in E. coli challenged with trimethoprim and can expand the mutational repertoire available to E. coli to evolve resistance. This multi-pronged influence of Lon on drug-resistance provides an illustrative instance of how master regulators shape the response of bacteria to antibiotics.